头颈癌液体活检:生物流体、分析物与分子特征的最新进展
本文综述头颈癌液体活检的最新进展,涵盖病毒相关与非病毒相关肿瘤,评估多种生物流体、分析物及分子谱分析方法。靶向外周血浆病毒DNA的液体活检已建立临床性能,多重生物流体与分析物或可提高检测灵敏度与临床适用性,标准化与统一化对临床转化至关重要。
要点
- 靶向外周血浆病毒DNA的液体活检已建立临床性能,效用研究正在进行。
- 采用多种生物流体来源和分析物可能提高检测灵敏度和临床适用性。
- 分析方法的标准化与统一化对生物标志物发现和可靠临床实施至关重要。
核心结论
- 使用多种生物流体来源和分析物可能提高检测灵敏度和临床适用性。
- 分析方法的标准化与统一化对于增强生物标志物发现和实现可靠临床实施至关重要。
研究设计与样本
- 综述头颈癌液体活检的最新进展,涵盖病毒相关与非病毒相关癌症,评估多种生物流体、分析物和分子谱分析方法。
主要发现
- 靶向外周血浆病毒DNA的液体活检测定已建立临床性能,效用研究正在进行,为其他新兴测定提供了蓝图。
- 分子异质性给液体活检检测带来挑战,但新兴方法为临床效用提供了有前景的途径。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Head and neck cancers (HNCs) are too often diagnosed at advanced stages when outcomes are poor. Additionally, robust tools for the early detection of recurrence remain elusive. These gaps drive interest in so-called liquid biopsy approaches for HNC detection, prognostication, and surveillance. Molecular heterogeneity presents challenges to liquid biopsy testing, but emerging approaches provide promising avenues toward clinical utility. METHODS: We review the latest developments in HNC liquid biopsies, provide perspectives on viral-associated and nonviral-associated cancers, and assess various biofluids, analytes, and molecular profiling approaches. RESULTS: Liquid biopsy assays targeting viral DNA from peripheral blood plasma have established clinical performance, and utility studies are ongoing, serving as a blueprint for other emerging assays. CONCLUSION: The use of multiple biofluid sources and analytes may improve detection sensitivity and clinical applicability. Standardization and harmonization of analysis methods will be critical for enhancing biomarker discovery and enabling reliable clinical implementation.
引用
- Brooks PJ, Bratman SV. Liquid Biopsies in Head and Neck Cancers: Recent Developments Across Biofluids, Analytes, and Molecular Features. Head Neck. 2025. PMID: 40772381. doi:10.1002/hed.70009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。